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Perinatal risk indicators for long-term neurological
morbidity among preterm neonates
Margreet J. Teune, MD, MSc; Aleid G. van Wassenaer, MD, PhD; Paula van Dommelen, PhD;
Ben Willem J. Mol, MD, PhD; Brent C. Opmeer, PhD; for the Dutch POPS-19 Collaborative Study GroupcOBJECTIVE: Many obstetric interventions are performed to improve
long-term neonatal outcome. However, long-term neonatal outcome is
usually not a primary outcome because it is time-consuming and ex-
pensive. The aim of this project was to identify different perinatal risk
indicators and to develop prediction models for neurologic morbidity at
2 and 5 years of age.
STUDY DESIGN: Data from a Dutch cohort study of preterm and small-
for-gestational-age infants was used. Neonates who were born in The
Netherlands in 1983 with a gestational age of34 weeks and without
congenital abnormalities were included (n 753). Infants were divided
in 3 groups: no handicap, minor handicap, and major handicap.
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396.e1 American Journal of Obstetrics& Gynecology MAY 2011RESULTS: Common risk indicators for major handicaps at 2 and 5 years
of age were male sex (odds ratio, 2.7 and 3.0, respectively), seizures
after2 days of life (odds ratio, 5.8 and 5.8, respectively), and intra-
ranial hemorrhage (odds ratio, 3.8 and 2.6, respectively).
CONCLUSION: In this cohort, male sex, intracranial hemorrhage, and
seizures seem to be important risk indicators for long-term neurologic
morbidity.
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BMany obstetric interventions are per-formed to improve both short- and
long-term outcome. Evaluation of the
long-term effect of a perinatal interven-
tion is necessary because serious se-
quelae from perinatal complications fre-
quently manifest themselves only after
several years. Nevertheless, long-term
follow-up evaluation is time-consum-
ing, expensive, beyond obstetricians’
awareness, and falls outside the funding
period of most obstetric studies. Conse-
quently, obstetric interventions usually
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One way to overcome this problem
would be to model long-term conse-
quences on the basis of short-term neo-
natal outcomes. This could be realized by
the development of prediction models in
which the association between short-
term and long-term outcomes is deter-
mined statistically and adjusted for rele-
vant covariates.
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/j.ajog.2011.02.055Subsequently, these prediction models
for long-term neurologic morbidity
could be used to extrapolate short-term
outcomes on the neurologic status of ne-
onates or to indicate for which neonates
neurologic long-term follow-up evalua-
tion is required, as their outcomes (ei-
ther absence or presence of sequelae)
cannot be predicted from short-term
outcomes and clinical background char-
acteristics. The development of such
models requires a longitudinal approach
in which data surrounding pregnancy,
delivery, and short-term outcomes and
follow-up data are available on various
health-related outcomes.
The Dutch project on preterm and
small-for-gestational-age infants (POPS)
cohort is one of the few birth cohorts
with a systematic assessment of these
data. Data of all Dutch infants who were
born alive in 1983 with a gestational age
of 32 completed weeks and/or with a
birthweight of 1500 g were collected
prospectively.1-5 This birth cohort could
rovide insight in the long-term conse-
uences of perinatal outcomes.
In the literature, many risk indicators
or neurologic morbidity are mentioned.







































































www.AJOG.org Obstetrics Researchture sharply increase the risk for neuro-
logic morbidity, but these conditions
fortunately are uncommon and even
sometimes not survived; individually
and collectively, these indicators account
for only a small portion of neurologic
morbidity. Although any other indica-
tor, if severe, may be sufficient to cause
neurologic morbidity, more often it is
the presence of multiple risk indicators
that causes neurologic morbidity later in
life.6 Development of multivariable pre-
iction models for neurologic morbidity
an increase our understanding of pre-
ictors for neurologic morbidity and can
elp us to develop interventions to pre-
ent these complications in the future.
In this study, we aimed to identify dif-
erent perinatal risk indicators for long-
erm neurologic morbidity and to use
hese perinatal risk indicators to develop
rediction models for long-term neuro-
ogic morbidity at 2 and 5 years of age.
MATERIALS AND METHODS
Study design
For the development of prediction mod-
els for long-term neurologic morbidity,
we used data that were available from a
Dutch cohort study of preterm and/or
small-for-gestational-age infants (POPS
study). In this cohort, all of the live born
infants who were included were deliv-
ered in The Netherlands between Janu-
ary and December 1983, either at 32
completed weeks of gestation and/or
with a birthweight of1500 g. The study
ultimately consisted of 1338 infants,
which was 94% of the eligible infants
who had been born in 1983 in The Neth-
erlands.1-5 Because of the “mixed meta-
phor” of combining gestational age and
low birthweight in this cohort, only in-
fants with gestational age of 34 weeks
were included in our analysis. Infants with
congenital abnormalities were excluded.
Outcomes
Endpoints that were used for this predic-
tion model were neurologic morbidity at
2 and 5 years of age. The follow-up eval-
uation until the age of 2 years was carried
out by local pediatricians all over The
Netherlands. An overall developmental
level was done with the Gesell test that
had been adapted for Dutch children and oalso neurologic, visual, and hearing ex-
aminations had been performed.
According to the outcome, the data
were divided into 3 groups: no handicap,
minor handicap, and major handicap.
The infant was considered to have no
handicap when developmental delay was
absent (developmental quotient 90)
and there were no motor, visual, or hear-
ing disabilities. A minor handicap was
diagnosed when some delay was present
(3-4 months retarded or developmental
quotient between 80 and 90) and/or at
least one of the following handicaps: a
mild cerebral paresis (such a slight hemi-
paresis or quadriparesis), mild visual or
hearing defects, or moderate psychoso-
cial problems. Such disabilities were un-
likely to prevent the child from going to a
normal school or to interfere seriously
with normal life. A major handicap was
diagnosed when severe retardation was
present (5 months delay or develop-
mental quotient80) and/or at least one
of the following handicaps: a severe cere-
bral paresis, severe visual or hearing de-
fects, or serious psychologic problems.
Such disabilities probably would stop the
child from going to a normal school or
cause serious interference with normal
functioning in society.
At 5 years chronologic age, a follow-up
program was carried out by 3 specially
trained pediatricians during a visit to the
home. Eight areas of development were
assessed: neuromotor function (Tou-
wen7); mental development (Denver de-
velopmental screening test)8; hearing
unction (audiometry/otoscopy); visual
unction; language and speech develop-
ent (Standardized Dutch Test; Ger-
itsen9); musculoskeletal system (physical
xamination) and respiratory morbidity
parents’ questionnaire). In each area,
n infant was categorized as impaired,
isabled, or handicapped, according to
orld Health Organization defini-
ions.10 An infant was regarded as hand-
capped at 5 years of age if he or she had a
andicap in an area of examination. In-
ants who needed special education as a
esult of 1 impairments or disabilities
ere considered to be at least minor
andicapped. A handicap was consid-
red minor if it did not interfere seri-
usly with everyday life and did not re-
MAY 2011 Americuire extensive caretaking and major
hen it did interfere with everyday life
nd when it led to a life of dependency or
nstitutionalization.5,10
Candidate predictors
Candidate predictors for neurodevelop-
ment handicaps were determined on the
basis of existing literature of perinatal pre-
dictors for long-term neurologic morbid-
ity, combined with consulting experts in
the field.6,11-15 The following candidate
redictors were included in the analysis:
ocial class, ethnicity, education level of the
other (low, moderate, high), maternal
moking, hypertension before pregnancy,
regnancy-induced hypertension (dia-
tolic pressure90 mm Hg), preeclamp-
ia/eclampsia, maternal epilepsy, diabetes
ellitus, gestational diabetes mellitus,
ultiple pregnancy, vertex or other pre-
entation, prolonged rupture of mem-
ranes, meconium-stained fluid, gluco-
orticosteroids, small for gestational age
10th percentile), gestational age, sex,
eonatal asphyxia, respiratory distress syn-
rome, bronchopulmonary dysplasia, sei-
ures, intracranial hemorrhage, necrotiz-
ng enterocolitis, hyperbilirubinemia,
epsis (blood culture proven), and dura-
ion of mechanical ventilation (continu-
us or intermittent).
Neonatal asphyxia was defined as low
-minute Apgar score (7) and/or um-
ilical cord acidosis (pH 7.05). Bron-
hopulmonary dysplasia was defined as
linical signs of respiratory distress, with
n abnormal chest X-ray and an oxygen
equirement after 28 days of age (criteria of
ancalari et al16). Intracranial hemorrhage
was defined as a clinical diagnosis (based
on rapid or salutatory deterioration, fall in
hematocrit level) and/or ultrasound scans
or computed tomography. All seizures
(clinical definition: including subtle sei-
zures, generalized tonic, multifocal clonic,
focal clonic, and myoclonic seizures) were
recorded as either absent or as present on
day 1 of life or day 2 of life or later.
Statistical analysis
We developed 4 multivariable logistic re-
gression models in which we analyzed
the association between the candidate
predictors and infants with minor or
major handicap vs infants with no hand-







































































































Research Obstetrics www.AJOG.orgicap and infants with major handicap vs
infants with no or minor handicap at 2
and 5 years of age. Multiple imputations
were used to adjust for missing values.
We created 5 imputed datasets that were
based on the candidate predictors men-
tioned earlier and all available outcome-
specific data at 2 and 5 years of age. Im-
puted values were limited to the lowest
and highest values that were observed
for the measured outcome variable. Un-
certainty about imputed values is re-
flected in differences between different
imputed datasets and incorporated in
the estimated standard errors and as-
sociated probability values for the
pooled model. We used SPSS software
(version 17.0; SPSS Inc, Chicago, IL)
for the imputation. The imputation
method in SPSS software is based
largely on the chained equations ap-
proach in multivariate imputation by
chained equations (MICE).17
After imputation, the prevalence of
the candidate predictors was first ana-
lyzed. Thereafter, a univariable and mul-
tivariable regression analysis was per-
formed to estimate odds ratios (ORs),
95% confidence interval [CI], and corre-
sponding probability values for dichoto-
mous and continuous variables. Because
the use of too stringent probability values
for variable selection is more deleterious
for a model than including too many fac-
tors, all variables that showed a signifi-
cance level of .50 in univariable analyses
were entered in the multivariable logistic
regression model.18 Furthermore, we
sed a stepwise backward selection pro-
edure with a predefined significance
evel of  .20 for removing variables
from the models.19 Variables that re-
ained in the last step of the backward
election procedure in at least 4 of the 5
mputed datasets were included in the
nal logistic regression analysis. Dis-
riminative capacity of the models was
valuated by calculation of the area un-
er the curve. Calibration of the mod-
ls was assessed by comparison of the
alculated probabilities with the ob-
erved proportion of neurologic mor-
idity. The goodness-of-fit was tested
ormally with the Hosmer and Leme-
how test statistic. Data were analyzed
ith the SPSS software. w
396.e3 American Journal of Obstetrics& GynecoloRESULTS
Sample and respiratory
morbidity incidence
Of the original cohort of 1338 infants,
1026 infants survived the neonatal pe-
riod (28 days); 969 infants were alive at
2 years of age; 966 infants were alive at 5
years of age, and 959 infants were alive at
19 years of age. The risk of death in the
first 28 days of life was equal for boys and
girls. Because of the “mixed metaphor”
of the combination of gestational age
and low birthweight in this cohort, in-
fants with a gestational age of34 weeks
were excluded (n  136). Because con-
enital malformations were considered
o influence neurologic function, all in-
ants with congenital abnormalities were
lso excluded (n  70), which left 753
nfants for the final analysis. At 2 years of
ge, information on neurologic morbid-
ty was missing for 23 infants (follow-up
ate, 97%). At 5 years of age, information
n neurologic morbidity was missing for
3 infants (follow-up rate, 96%). At 2
ears of age, the rate of infants with no
andicap, minor handicap, or major
andicap was 83.2% (n  607 infants),
1.5% (n  84 infants), and 5.3% (n 
9 infants), respectively, before imputa-
ion and 81.5% (n 614 infants), 11.7%
n  88 infants), and 6.8% (n  51 in-
ants), respectively, after imputation. At
years of age, the rate of infants with no
andicap, a minor handicap, or a major
andicap was 86.0% (n  619 infants),
.3% (n 60 infants), and 5.7% (n 41
infants), respectively, before imputation
and 84.5% (n 636 infants), 9.4% (n
71 infants), and 6.1% (n  46 infants),
respectively, after imputation.
Univariable and multivariable models
Neurologicmorbidityat2yearsofage. Tables
1 and 2 show the results of the univari-
ble and multivariable regression analy-
is for neurologic morbidity at 2 years of
ge. Male sex (adjusted OR [aOR], 1.6;
5% CI, 1.1–2.4) and intracranial hem-
rrhage that was diagnosed with ultra-
ound scanning or computed tomogra-
hy (aOR, 2.3; 95% CI, 1.2– 4.3) were
ignificant risk indicators for minor/ma-
or handicaps at 2 years of age (Table 1).
isk indicators for major handicaps only
ere male sex (aOR, 2.7; 95% CI, 1.2–5.8), y
gy MAY 2011eizures at2 days of life (aOR, 5.8; 95%
I, 1.9–17.8), intracranial hemorrhage
hat was diagnosed with ultrasound scan-
ing or computed tomography (aOR, 3.8;
5% CI, 1.6 –9.1) and hyperbiliru-
inemia (aOR, 2.6; 95% CI, 1.2–5.3).
urprisingly, maternal smoking (1-10
ig/d) seemed to decrease the risk for
ajor handicaps (aOR, 0.32; 95% CI,
.12– 0.88) (Table 2).
eurologicmorbidityat5yearsofage. Tables
and 4 show the results of the univari-
ble and multivariable regression analy-
is for neurologic morbidity at 5 years of
ge. Multiple pregnancy (aOR, 1.8; 95%
I, 1.1–3.1), low birthweight (aOR, 1.8;
5% CI, 1.1–3.0), male sex (aOR, 2.2; 95%
I, 1.4–3.6), bronchopulmonary dyspla-
ia (aOR, 2.0; 95% CI, 1.1–3.8), and intra-
ranial hemorrhage that was diagnosed
ith ultrasound scanning or computed to-
ography (aOR, 2.5; 95% CI, 1.2–5.4)
ere significant risk indicators for mi-
or/major handicaps (Table 3). Higher
ocial class decreased the risk for neuro-
ogic morbidity (aOR, 0.40; 95% CI,
.19 – 0.87). Risk indicators for major
andicaps only were male sex (aOR, 3.0;
5% CI, 1.1– 8.0), seizures at2 days of
ife (aOR, 5.8; 95% CI, 1.9 –17.9), and
ntracranial hemorrhage that was diag-
osed with ultrasound scanning or com-
uted tomography (aOR, 2.6; 95% CI,
.02– 6.8) (Table 4).
odel performance. The 4 prediction
odels (that compared infants with mi-
or or major handicap vs infants without
handicap and infants with a major
andicap vs infants with no handicap or
inor handicap) discriminated mod-
stly well between diseased and nondis-
ased infants with an area under the
urve of 0.67 (95% CI, 0.62– 0.72) and
.76 (95% CI, 0.69 – 0.83) at 2 years of
ge, respectively, and an area under the
urve of 0.74 (95% CI, 0.69 – 0.79) and
.74 (95% CI, 0.67– 0.81) at 5 years of
ge, respectively. Overall, the 4 predic-
ion models showed good calibration
Figures 1 and 2). Nevertheless, the cali-
ration for neurologic morbidity at 2
ears of age seems better than the cali-
ration for neurologic morbidity at 5
ears of age, but this is understandable
www.AJOG.org Obstetrics ResearchTABLE 1
Risk indicators for neurological morbidity (2 years); infants with minor/major




Univariable analysis (pooled) Multivariable analysis (pooled)
Crude odds ratio
(95% CI) P value
Adjusted odds ratio





Both parents white 637 (85%) 1.2 (0.68–2.2) .489
..............................................................................................................................................................................................................................................................................................................................................................
One/both parents Mediterranean 41 (5%) 1.1 (0.41–3.0) .824
..............................................................................................................................................................................................................................................................................................................................................................
One/both parents black 31 (4%) 0.54 (0.16–1.8) .322
..............................................................................................................................................................................................................................................................................................................................................................






Low 295 (39%) 1.0
..............................................................................................................................................................................................................................................................................................................................................................
Moderate 275 (37%) 0.76 (0.46–1.2) .274
..............................................................................................................................................................................................................................................................................................................................................................




Low 423 (56%) 0.84 (0.48–1.5) .531
..............................................................................................................................................................................................................................................................................................................................................................




Maternal smoking during pregnancy per day
..............................................................................................................................................................................................................................................................................................................................................................
No 493 (65%) 1.0
..............................................................................................................................................................................................................................................................................................................................................................
1-10 147 (20%) 1.05 (0.64–1.7) .860
..............................................................................................................................................................................................................................................................................................................................................................
10 112 (15%) 1.4 (0.82–2.4) .220
.......................................................................................................................................................................................................................................................................................................................................................................
Hypertension before pregnancy 34 (5%) 0.74 (0.28–2.0) .548
.......................................................................................................................................................................................................................................................................................................................................................................




Multiple pregnancy 172 (23%) 1.0 (0.64–1.6) .995
.......................................................................................................................................................................................................................................................................................................................................................................




No 715 (95%) 1.0
..............................................................................................................................................................................................................................................................................................................................................................
With diet 22 (3%) 0.43 (0.1–1.9) .258
..............................................................................................................................................................................................................................................................................................................................................................




No 583 (77%) 1.0
..............................................................................................................................................................................................................................................................................................................................................................
90 mm Hg 110 (15%) 0.73 (0.41–1.3) .281
..............................................................................................................................................................................................................................................................................................................................................................
Preeclampsia/eclampsia 60 (8%) 0.68 (0.32–1.5)
.......................................................................................................................................................................................................................................................................................................................................................................
Prolonged rupture of membranes
..............................................................................................................................................................................................................................................................................................................................................................
No 440 (58%) 1.0
..............................................................................................................................................................................................................................................................................................................................................................
1-11 h 127 (17%) 1.2 (0.69–1.9) .611
..............................................................................................................................................................................................................................................................................................................................................................
12-24 h 28 (4%) 1.4 (0.50–3.8) .544
..............................................................................................................................................................................................................................................................................................................................................................
1-7 D 106 (14%) 1.05 (0.60–1.9) .855
..............................................................................................................................................................................................................................................................................................................................................................
7 D 53 (7%) 1.5 (0.74–2.9) .271
................................................................................................................................................................................................................................................................................................................................................................................Teune. Perinatal risk indicators for long-term neurological morbidity. Am J Obstet Gynecol 2011. (continued )
MAY 2011 American Journal of Obstetrics& Gynecology 396.e4
l mo
Research Obstetrics www.AJOG.orgbecause it is harder to predict an out-
come later in life. The Hosmer-Leme-
show goodness-of-fit test was not signif-
icant for all 4 prediction models.
COMMENT
We developed 4 prediction models for
TABLE 1
Risk indicators for neurological mo































































Teune. Perinatal risk indicators for long-term neurologicaneurologic morbidity at 2 and 5 years of
396.e5 American Journal of Obstetrics& Gynecoloage for infants who were delivered in The
Netherlands (1983) at34 weeks of ges-
tation. We developed models to predict
which infants would develop any handi-
cap compared with completely healthy
infants, and we developed models to pre-
dict which infants would experience a







41 (5%) 1.3 (0.57–3.0)
.........................................................................................................................













197 (26%) 0.95 (0.62–1.5)
.........................................................................................................................
396 (53%) 1.7 (1.2–2.5)
.........................................................................................................................
71 (9%) 2.3 (1.2–4.3)
.........................................................................................................................





111 (15%) 1.02 (0.58–1.8)
.........................................................................................................................
221 (29%) 1.3 (0.87–2.0)
.........................................................................................................................





4 (1%) 2.3 (0.19–27.5)
.........................................................................................................................





41 (5%) 1.5 (0.71–3.3)
.........................................................................................................................
58 (8%) 2.9 (1.6–5.3)
.........................................................................................................................
42 (6%) 2.1 (1.02–4.4)
.........................................................................................................................
212 (28%) 1.5 (1.01–2.4)
.........................................................................................................................
78 (10%) 1.5 (0.83–2.6)
.........................................................................................................................
mean  2 days 1.03 (0.99–1.1)
.........................................................................................................................
mean  3 days 1.04 (1.01–1.1)
.........................................................................................................................
rbidity. Am J Obstet Gynecol 2011.major handicap compared with infants
gy MAY 2011who experienced no handicap or, at
maximum, a minor handicap.
The 4 prediction models discrimi-
nated modestly well between infants
with and without handicaps and showed
good calibration. The relative impor-
tance of discrimination and calibration
r
led) Multivariable analysis (pooled)
alue
Adjusted odds ratio














6 1.6 (1.1–2.4) .014
..................................................................................................................















0 2.6 (0.20–34.4) .469
..................................................................................................................





9 0.94 (0.41–2.1) .874
..................................................................................................................
0 2.3 (1.2–4.3) .009
..................................................................................................................
6 2.1 (0.95–4.5) .069
..................................................................................................................
7 1.5 (0.97–2.4) .071
..................................................................................................................

























































......... .........depends on the clinical applications of a
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Risk indicators for neurological morbidity (2 years); infants with a major




Univariable analysis (pooled) Multivariable analysis (pooled)
Crude odds ratio
(95% CI) P value
Adjusted odds ratio





Both parents white 637 (85%) 1.2 (0.43–3.3) .724
..............................................................................................................................................................................................................................................................................................................................................................
One/both parents Mediterranean 41 (5%) 1.4 (0.28–6.8) .691
..............................................................................................................................................................................................................................................................................................................................................................
One/both parents black 31 (4%) 0.62 (0.07–5.1) .654
..............................................................................................................................................................................................................................................................................................................................................................






Low 295 (39%) 1.0
..............................................................................................................................................................................................................................................................................................................................................................
Moderate 275 (37%) 0.73 (0.35–1.5) .407
..............................................................................................................................................................................................................................................................................................................................................................




Low 423 (56%) 1.0
..............................................................................................................................................................................................................................................................................................................................................................
Moderate 131 (17%) 1.4 (0.60–3.4) .436
..............................................................................................................................................................................................................................................................................................................................................................
High 199 (26%) 1.1 (0.45–2.9) .784
.......................................................................................................................................................................................................................................................................................................................................................................
Maternal smoking during pregnancy per day
..............................................................................................................................................................................................................................................................................................................................................................
No 493 (65%) 1.0 1.0
..............................................................................................................................................................................................................................................................................................................................................................
1-10 147 (20%) 0.45 (0.18–1.2) .100 0.32 (0.12–0.88) .028
..............................................................................................................................................................................................................................................................................................................................................................
10 112 (15%) 0.62 (0.20–2.0) .429 0.61 (0.14–2.5) .501
.......................................................................................................................................................................................................................................................................................................................................................................
Hypertension before pregnancy 34 (5%) 1.000
.......................................................................................................................................................................................................................................................................................................................................................................




Multiple pregnancy 172 (23%) 1.5 (0.78–2.9) .218
.......................................................................................................................................................................................................................................................................................................................................................................




No 715 (95%) 1.0
..............................................................................................................................................................................................................................................................................................................................................................
With diet 22 (3%) 0.63 (0.08–4.8) .656
..............................................................................................................................................................................................................................................................................................................................................................




No 583 (77%) 1.0
..............................................................................................................................................................................................................................................................................................................................................................
90 mm Hg 110 (15%) 0.65 (0.24–1.8) .391
..............................................................................................................................................................................................................................................................................................................................................................
Preeclampsia/eclampsia 60 (8%) 0.56 (0.14–2.3) .417
.......................................................................................................................................................................................................................................................................................................................................................................
Prolonged rupture of membranes
..............................................................................................................................................................................................................................................................................................................................................................
No 440 (58%) 1.0
..............................................................................................................................................................................................................................................................................................................................................................
1-11 h 127 (17%) 1.7 (0.78–3.5) .191
..............................................................................................................................................................................................................................................................................................................................................................
12-24 h 28 (4%) .999
..............................................................................................................................................................................................................................................................................................................................................................
1-7 d 106 (14%) 1.2 (0.46–3.1) .716
..............................................................................................................................................................................................................................................................................................................................................................
7 d 53 (7%) 0.76 (0.19–3.1) .708
................................................................................................................................................................................................................................................................................................................................................................................Teune. Perinatal risk indicators for long-term neurological morbidity. Am J Obstet Gynecol 2011. (continued )
MAY 2011 American Journal of Obstetrics& Gynecology 396.e6
l mo
Research Obstetrics www.AJOG.orgmodel. Because our models are intended
to evaluate the neurologic long-term ef-
fects of perinatal interventions, the accu-
racy of the numeric probability (calibra-
tion) is relevant, less so than to identify
adequately those infants with and with-
TABLE 2
Risk indicators for neurological mo































































Teune. Perinatal risk indicators for long-term neurologicaout long-term neurologic morbidity.20
396.e7 American Journal of Obstetrics& GynecoloOne major strength of this study is the
relatively large national cohort with high
follow-up rates that allows for a popula-
tion-based prospective evaluation of the
association between perinatal and de-
mographic risk indicators on long-term







41 (5%) 0.73 (0.12–4.3)
.........................................................................................................................













197 (26%) 1.1 (0.54–2.2)
.........................................................................................................................
396 (53%) 2.6 (1.3–5.3)
.........................................................................................................................
71 (9%) 1.03 (0.37–2.9)
.........................................................................................................................





111 (15%) 1.3 (0.57–2.9)
.........................................................................................................................
221 (29%) 0.85 (0.41–1.7)
.........................................................................................................................





4 (1%) 6.4 (0.58–70.7)
.........................................................................................................................





41 (5%) 1.6 (0.47–5.2)
.........................................................................................................................
58 (8%) 4.8 (2.1–10.8)
.........................................................................................................................
42 (6%) 0.91 (0.15–5.4)
.........................................................................................................................
212 (28%) 2.2 (1.2–4.0)
.........................................................................................................................
78 (10%) 1.8 (0.81–4.0)
.........................................................................................................................
mean  2 days 1.05 (1.00–1.1)
.........................................................................................................................
mean  3 days 1.04 (1.01–1.08)
.........................................................................................................................
rbidity. Am J Obstet Gynecol 2011.neurologic morbidity. Handicaps were
gy MAY 2011defined in a comprehensive way by tak-
ing general health, cerebral paresis, and
hearing, vision, language, and mental
development into account.
A relative limitation is that the in-
fants in our cohort were born in 1983.
led) Multivariable analysis (pooled)
alue
Adjusted odds ratio































0 10.7 (0.67–172.0) .096
..................................................................................................................





5 0.68 (0.16–2.9) .602
..................................................................................................................




7 2.6 (1.2–5.3) .014
..................................................................................................................
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Risk indicators for neurological morbidity (5 years); infants with minor/major




Univariable analysis (pooled) Multivariable analysis (pooled)
Crude odds ratio
(95% CI) P value
Adjusted odds ratio





Both parents white 637 (85%) 1.6 (0.82–3.0) .172
..............................................................................................................................................................................................................................................................................................................................................................
One/both parents Mediterranean 41 (5%) 0.87 (0.30–2.5) .793
..............................................................................................................................................................................................................................................................................................................................................................
One/both parents black 31 (4%) 1.00 (0.34–3.0) .996
..............................................................................................................................................................................................................................................................................................................................................................






Low 295 (39%) 1.0 1.0
..............................................................................................................................................................................................................................................................................................................................................................
Moderate 275 (37%) 0.68 (0.43–1.1) .093 0.61 (0.35–1.1) .091
..............................................................................................................................................................................................................................................................................................................................................................




Low 423 (56%) 1.0 1.0
..............................................................................................................................................................................................................................................................................................................................................................
Moderate 131 (17%) 1.3 (0.77–2.3) .308 1.9 (0.94–3.7) .077
..............................................................................................................................................................................................................................................................................................................................................................
High 199 (26%) 0.65 (0.33–1.3) .219 1.1 (0.49–2.5) .804
.......................................................................................................................................................................................................................................................................................................................................................................
Maternal smoking during pregnancy per day
..............................................................................................................................................................................................................................................................................................................................................................
No 493 (65%) 1.0
..............................................................................................................................................................................................................................................................................................................................................................
1-10 147 (20%) 0.89 (0.50–1.6) .685
..............................................................................................................................................................................................................................................................................................................................................................
10 112 (15%) 1.1 (0.58–2.0) .814
.......................................................................................................................................................................................................................................................................................................................................................................
Hypertension before pregnancy 34 (5%) 0.70 (0.24–2.1) .519
.......................................................................................................................................................................................................................................................................................................................................................................




Multiple pregnancy 172 (23%) 1.8 (1.2–2.9) .009 1.8 (1.1–3.1) .022
.......................................................................................................................................................................................................................................................................................................................................................................




No 715 (95%) 1.0 1.0
..............................................................................................................................................................................................................................................................................................................................................................
With diet 22 (3%) 2.0 (0.77–5.3) .151 2.9 (0.98–8.4) .055
..............................................................................................................................................................................................................................................................................................................................................................




No 583 (77%) 1.0
..............................................................................................................................................................................................................................................................................................................................................................
90 mm Hg 110 (15%) 0.71 (0.4–1.3) .281
..............................................................................................................................................................................................................................................................................................................................................................
Preeclampsia/eclampsia 60 (8%) 0.55 (0.23–1.3) .180
.......................................................................................................................................................................................................................................................................................................................................................................
Prolonged rupture of membranes
..............................................................................................................................................................................................................................................................................................................................................................
No 440 (58%) 1.0
..............................................................................................................................................................................................................................................................................................................................................................
1-11 h 127 (17%) 1.2 (0.65–2.1) .607
..............................................................................................................................................................................................................................................................................................................................................................
12-24 h 28 (4%) 1.2 (0.40–3.6) .749
..............................................................................................................................................................................................................................................................................................................................................................
1-7 d 106 (14%) 0.91 (0.45–1.8) .785
..............................................................................................................................................................................................................................................................................................................................................................
7 d 53 (7%) 1.4 (0.67–3.0) .371
................................................................................................................................................................................................................................................................................................................................................................................Teune. Perinatal risk indicators for long-term neurological morbidity. Am J Obstet Gynecol 2011. (continued )








Research Obstetrics www.AJOG.orgneonatal care has improved the sur-
vival of increasingly premature infants,
but the prevalence of moderate-to-se-
vere disabilities (such as cerebral palsy)
remains high. Like mortality rates,
rates of disability generally increase
with decreasing gestational age and
TABLE 3
Risk indicators for neurological mo































































Teune. Perinatal risk indicators for long-term neurologicabirthweight.21
396.e9 American Journal of Obstetrics& GynecoloIn a Canadian population-based study
that was initiated in 2005, the prevalence
of cerebral palsy at 2 years of age was
9.8% among 172 infants who were born
at 22-28 weeks of gestation. The prevalence
of cerebral palsy in the same regional area
in 1991-1992 among 225 infants was







41 (5%) 1.2 (0.51–2.9)
.........................................................................................................................













197 (26%) 1.4 (0.92–2.2)
.........................................................................................................................
396 (53%) 2.7 (1.7–4.2)
.........................................................................................................................
71 (9%) 1.9 (0.98–3.6)
.........................................................................................................................





111 (15%) 1.4 (0.76–2.5)
.........................................................................................................................
221 (29%) 1.6 (0.98–2.5)
.........................................................................................................................





4 (1%) 2.3 (0.21–24.3)
.........................................................................................................................





41 (5%) 1.2 (0.48–3.0)
.........................................................................................................................
58 (8%) 2.9 (1.5–5.6)
.........................................................................................................................
42 (6%) 0.87 (0.32–2.4)
.........................................................................................................................
212 (28%) 1.3 (0.76–2.0)
.........................................................................................................................
78 (10%) 1.4 (0.75–2.7)
.........................................................................................................................
mean  2 days 1.03 (0.99–1.1)
.........................................................................................................................
mean  3 days 1.04 (1.01–1.07)
.........................................................................................................................
rbidity. Am J Obstet Gynecol 2011.11%.22 Rates of severe developmental de- u
gy MAY 2011ay and severe disability were lower in
005 (3.7%/3.7%, respectively) than in
he very preterm survivors who were
orn in 1991-1992 and 1997 (7.3%/7.8%
nd 14.8%/15.4%, respectively).
Furthermore, the prevalence of hand-
caps at 2 and 5 years of age is probably
r
led) Multivariable analysis (pooled)
alue
Adjusted odds ratio












5 1.8 (1.1–3.0) .015
..................................................................................................................
0 2.2 (1.4–3.6) .001
..................................................................................................................
2 1.8 (0.86–3.6) .124
..................................................................................................................













8 3.1 (0.27–35.9) .363
..................................................................................................................





6 0.96 (0.34–2.7) .938
..................................................................................................................































































......... .........nderestimated in the POPS cohort be-
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Risk indicators for neurological morbidity (5 years); infants with a major




Univariable analysis (pooled) Multivariable analysis (pooled)
Crude odds ratio
(95% CI) P value
Adjusted odds ratio





Both parents white 637 (85%) 3.5 (0.60–20.7) .172
..............................................................................................................................................................................................................................................................................................................................................................
One/both parents Mediterranean 41 (5%) 0.54 (0.08–3.9) .548
..............................................................................................................................................................................................................................................................................................................................................................
One/both parents black 31 (4%) .999
..............................................................................................................................................................................................................................................................................................................................................................






Low 295 (39%) 1.0
..............................................................................................................................................................................................................................................................................................................................................................
Moderate 275 (37%) 1.4 (0.64–3.0) .410
..............................................................................................................................................................................................................................................................................................................................................................




Low 423 (56%) 1.0
..............................................................................................................................................................................................................................................................................................................................................................
Moderate 131 (17%) 1.5 (0.71–3.2) .280
..............................................................................................................................................................................................................................................................................................................................................................
High 199 (26%) 0.73 (0.19–2.9) .665
.......................................................................................................................................................................................................................................................................................................................................................................
Maternal smoking during pregnancy per day
..............................................................................................................................................................................................................................................................................................................................................................
No 493 (65%) 1.0
..............................................................................................................................................................................................................................................................................................................................................................
1-10 147 (20%) 0.71 (0.28–1.8) .465
..............................................................................................................................................................................................................................................................................................................................................................
10 112 (15%) 0.54 (0.15–1.9) .346
.......................................................................................................................................................................................................................................................................................................................................................................
Hypertension before pregnancy 34 (5%) 1.000
.......................................................................................................................................................................................................................................................................................................................................................................




Multiple pregnancy 172 (23%) 1.9 (0.96–3.7) .069 1.8 (0.86–3.7) .119
.......................................................................................................................................................................................................................................................................................................................................................................




No 715 (95%) 1.0
..............................................................................................................................................................................................................................................................................................................................................................
With diet 22 (3%) 1.000
..............................................................................................................................................................................................................................................................................................................................................................




No 583 (77%) 1.0
..............................................................................................................................................................................................................................................................................................................................................................
90 mm Hg 110 (15%) 0.52 (0.15–1.8) .299
..............................................................................................................................................................................................................................................................................................................................................................
Preeclampsia/eclampsia 60 (8%) 1.02 (0.34–3.0) .973
.......................................................................................................................................................................................................................................................................................................................................................................
Prolonged rupture of membranes
..............................................................................................................................................................................................................................................................................................................................................................
No 440 (58%) 1.0
..............................................................................................................................................................................................................................................................................................................................................................
1-11 h 127 (17%) 0.70 (0.26–1.9) .489
..............................................................................................................................................................................................................................................................................................................................................................
12-24 h 28 (4%) 0.89 (0.12–6.4) .906
..............................................................................................................................................................................................................................................................................................................................................................
1-7 d 106 (14%) 0.89 (0.37–2.2) .801
..............................................................................................................................................................................................................................................................................................................................................................
7 d 53 (7%) 0.54 (0.12–2.4) .413
................................................................................................................................................................................................................................................................................................................................................................................Teune. Perinatal risk indicators for long-term neurological morbidity. Am J Obstet Gynecol 2011. (continued )
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l mo
Research Obstetrics www.AJOG.orgcause the Gesell test and Denver devel-
opment test were assessed for screening
of cognitive and behavioral problems at
2 and 5 years of age, respectively. Al-
though these tests are good in the detec-
tion of severe developmental problems,
TABLE 4
Risk indicators for neurological mo































































Teune. Perinatal risk indicators for long-term neurologicathese tests have been criticized as unreli-
396.e11 American Journal of Obstetrics& Gynecoable in predicting less severe or specific
problems.
Another limitation is that cranial ul-
trasound scans were performed in only 6
of the 8 neonatal intensive care units in
The Netherlands in 1983, which proba-







41 (5%) 1.5 (0.48–4.9)
.........................................................................................................................













197 (26%) 1.1 (0.55–2.2)
.........................................................................................................................
396 (53%) 2.9 (1.2–7.4)
.........................................................................................................................
71 (9%) 1.5 (0.48–4.7)
.........................................................................................................................





111 (15%) 2.3 (1.02–5.2)
.........................................................................................................................
221 (29%) 1.3 (0.58–2.7)
.........................................................................................................................





4 (1%) 7.2 (0.68–75.9)
.........................................................................................................................





41 (5%) 2.3 (0.72–7.0)
.........................................................................................................................




212 (28%) 1.8 (0.96–3.5)
.........................................................................................................................
78 (10%) 1.3 (0.50–3.5)
.........................................................................................................................
mean  2 days 1.03 (0.97–1.09)
.........................................................................................................................
mean  3 days 1.02 (0.99–1.05)
.........................................................................................................................
rbidity. Am J Obstet Gynecol 2011.bly caused an underestimation of the
logy MAY 2011prevalence of intracranial hemorrhage.
This is further strengthened by the fact
that periventricular leukomalacia was
not yet diagnosed at that time. Neverthe-
less, intracranial hemorrhage is a strong
risk indicator for long-term neurologic
led) Multivariable analysis (pooled)
alue
Adjusted odds ratio
(95% CI) P value






























1 9.3 (0.84–103.6) .069
..................................................................................................................





5 1.1 (0.29–4.0) .917
..................................................................................................................































































......... .........morbidity in the POPS cohort. The same
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MAY 2011 Americanfinding is found in other studies, such as
the EPIPAGE (Etude Epidemiologique sur
les Petits Ages Gestationnels) cohort.23
Overall, male sex, intracranial hemor-
rhage, and seizures seemed important
risk indicators for the development of a
handicap at 2 and 5 years of age in sur-
viving infants. In our models, asphyxia
was not a significant risk indicator for the
occurrence of minor or major handi-
caps. The theory that asphyxia is the
main underlying cause of cerebral palsy
has also been challenged previously by
Nelson,6 who showed that perinatal as-
phyxia accounts for only a small propor-
tion of the cases of cerebral palsy, whereas
neurologic morbidity often follows the
presence of multiple risk indicators later in
life.
In the model for neurologic morbidity
at 2 years of age (comparison of infants
with major handicap with infants with
no or minor handicap), maternal smok-
ing was associated with a decreased risk
for neurologic morbidity. We do not
have an explanation for this result.
Neurologic morbidity is not only an
enormous burden for the individual in-
fant and their parents but also for soci-
ety. As a consequence, multiple multi-
center studies are performed nowadays
to search for interventions that can pre-
vent the incidence and severity of neuro-
logic morbidity.
Withthehelpof thesepredictionmodels
of long-term neurologic morbidity, future
obstetric studies can predict long-term
outcomes when follow-up evaluation is
not feasible. Modeling has several advan-
tages. It can be inexpensive, free of ethical
concerns over renewed approach of pa-
tients and fast; a computer model can sim-
ulate in minutes while follow up lasts
years. Modeling has some less obvious
benefits too because the process of con-
structing the model promotes systematic
thought and generates insights about the
nature of its components and how they
interact, which may help to identify areas
in which empiric research is most
needed, may help generate new epidemi-
ologic or clinical hypotheses, and may
help to produce novel ideas for useful in-
terventions. Of course, modeling also
has limitations. Despite model theory orFIGURE 1
Calibration plot at 2 years
A, Infants with minor/major handicap vs with no handicap. B, Infants with major handicap vs infants
ith no or minor handicap.
Teune. Perinatal risk indicators for long-term neurological morbidity. Am J Obstet Gynecol 2011.logic, inaccuracies in model parameters
Journal of Obstetrics& Gynecology 396.e12
Research Obstetrics www.AJOG.org
396.e13 American Journal of Obstetrics& Gynecology MAY 2011or omission of key factors can invalidate
results.24
Before our prediction that models can
be used in future obstetric studies to ex-
trapolate the short-term neonatal out-
comes to a longer study horizon, the
models should be validated in more re-
cent cohorts to investigate whether the
same risk indicators for neurologic mor-
bidity are found. Subsequently, these
risk indicators could be recommended as
primary endpoints in future obstetric
studies.
In this cohort, male sex, intracranial
hemorrhage, and seizures seem impor-
tant risk indicators for neurologic mor-
bidity at 2 and 5 years of age. This study
shows that the development of predic-
tion models for long-term neurologic
morbidity is possible; however, our find-
ings should be confirmed in more recent
cohorts. f
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